Privia Health Group, Inc. (PRVA) is a Medical - Healthcare Information Services company in the Healthcare sector, currently trading at $23.12. It has a SharesGrow Score of 66/100, indicating a above average investment profile with 3 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of PRVA = $22.51 (-2.6% from the current price, the stock appears fairly valued). Analyst consensus target is PRVA = $31 (+34.1% upside).
Valuation: PRVA trades at a trailing Price-to-Earnings (P/E) of 121.7 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 4.28.
Financials: revenue is $2.1B, +16.4%/yr average growth. Net income is $23M, growing at +104.3%/yr. Net profit margin is 1.1% (thin). Gross margin is 9.9% (+0 pp trend).
Balance sheet: total debt is $10M against $737M equity (Debt-to-Equity (D/E) ratio 0.01, conservative). Current ratio is 1.6 (strong liquidity). Debt-to-assets is 0.7%. Total assets: $1.4B.
Analyst outlook: 20 / 22 analysts rate PRVA as buy (91%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 31/100 (Fail), Growth 90/100 (Pass), Past 75/100 (Partial), Health 100/100 (Pass), Moat 35/100 (Fail), Future 100/100 (Pass), Income 30/100 (Fail).
